open access

Vol 26 (2023): Continuous Publishing
Clinical vignette
Submitted: 2022-06-21
Accepted: 2022-09-04
Published online: 2023-03-21
Get Citation

COVID-19 vaccination-related [18F]FDG-avid lymph node in a patient with marginal zone B-cell lymphoma

Paulina Ziolkowska1, Alicja Salyga12, Monika Joks3, Marek Ruchala1, Rafał Czepczynski12
·
Nucl. Med. Rev 2023;26:52-53.
Affiliations
  1. Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
  2. Department of Nuclear Medicine, Affidea, Poznan, Poland
  3. Department of Haematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland

open access

Vol 26 (2023): Continuous Publishing
Clinical vignette
Submitted: 2022-06-21
Accepted: 2022-09-04
Published online: 2023-03-21

Abstract

The [18F]FDG PET/CT is a crucial tool in the diagnostic process and monitoring of neoplastic diseases. Currently, during the global program of vaccination against COVID-19 and the possibility of axillary lymphadenopathy after this injection, the correct interpretation of PET/CT images is vitally significant and may create some difficulties.
We present a case of increased uptake of [18F]FDG in an axillary lymph node in a PET/CT scan performed 2 days after the Pfizer BioNTech COVID-19 vaccine in a 48-year-old patient newly diagnosed with marginal zone B-cell lymphoma.

Abstract

The [18F]FDG PET/CT is a crucial tool in the diagnostic process and monitoring of neoplastic diseases. Currently, during the global program of vaccination against COVID-19 and the possibility of axillary lymphadenopathy after this injection, the correct interpretation of PET/CT images is vitally significant and may create some difficulties.
We present a case of increased uptake of [18F]FDG in an axillary lymph node in a PET/CT scan performed 2 days after the Pfizer BioNTech COVID-19 vaccine in a 48-year-old patient newly diagnosed with marginal zone B-cell lymphoma.

Get Citation

Keywords

marginal zone B-cell lymphoma; PET/CT; COVID-19; vaccination; staging

About this article
Title

COVID-19 vaccination-related [18F]FDG-avid lymph node in a patient with marginal zone B-cell lymphoma

Journal

Nuclear Medicine Review

Issue

Vol 26 (2023): Continuous Publishing

Article type

Clinical vignette

Pages

52-53

Published online

2023-03-21

Page views

2444

Article views/downloads

267

DOI

10.5603/NMR.a2023.0004

Bibliographic record

Nucl. Med. Rev 2023;26:52-53.

Keywords

marginal zone B-cell lymphoma
PET/CT
COVID-19
vaccination
staging

Authors

Paulina Ziolkowska
Alicja Salyga
Monika Joks
Marek Ruchala
Rafał Czepczynski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl